Effects of sphingomyelin on apolipoprotein E- and lipoprotein lipase-mediated cell uptake of lipid particles

被引:33
作者
Morita, S
Okuhira, K
Tsuchimoto, N
Vertut-Doï, A
Saito, H
Nakano, M
Handa, T [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan
[2] Natl Inst Hlth Sci, Osaka Branch, Osaka 5400006, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2003年 / 1631卷 / 02期
基金
日本学术振兴会;
关键词
sphingomyelin; apolipoprotein E; apolipoprotein C; lipoprotein lipase; cell uptake;
D O I
10.1016/S1388-1981(02)00365-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been reported that human plasma sphingomyelin (SM) levels are positively and independently related to coronary artery disease. The lipoprotein surface is mainly formed by phosphatidylcholine (PC) and SM together with cholesterol and apolipoproteins. However, the influence of SM on the cell uptake of triglyceride-rich lipoproteins and remnants is poorly understood. To clarify the role of SM in lipoprotein uptake, we prepared lipid emulsions containing triolein, PC and SM as model particles of lipoproteins. Apolipoprotein E (ApoE) binding studies revealed that incorporation of SM into the emulsion surface reduced the binding capacity of apoE without changing the affinity. Surface SM reduced apoE-mediated uptake of emulsions by HepG2 cells because of the decreased amount of binding apoE. Apolipoproteins C-II and C-III inhibited the apoE-mediated uptake of SM containing emulsions more effectively. The stimulatory effect of lipoprotein lipase (LPL) on emulsion uptake was decreased by replacing surface PC with SM. These results suggest that SM-induced changes in the binding properties of apolipoproteins and LPL correlate with decreased hepatic uptake of lipid particles. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 66 条
[1]   MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APOLIPOPROTEIN-(APO)-CIII TRANSGENIC MICE - DIMINISHED VERY LOW-DENSITY-LIPOPROTEIN FRACTIONAL CATABOLIC RATE ASSOCIATED WITH INCREASED APO-CIII AND REDUCED APO-E ON THE PARTICLES [J].
AALTOSETALA, K ;
FISHER, EA ;
CHEN, XL ;
CHAJEKSHAUL, T ;
HAYEK, T ;
ZECHNER, R ;
WALSH, A ;
RAMAKRISHNAN, R ;
GINSBERG, HN ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1889-1900
[2]   Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions [J].
Arimoto, I ;
Matsumoto, C ;
Tanaka, M ;
Okuhira, K ;
Saito, H ;
Handa, T .
LIPIDS, 1998, 33 (08) :773-779
[3]  
Arimoto I, 1998, J LIPID RES, V39, P143
[4]   SPHINGOMYELINS IN BILAYERS AND BIOLOGICAL-MEMBRANES [J].
BARENHOLZ, Y ;
THOMPSON, TE .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 604 (02) :129-158
[5]  
BARENHOLZ Y, 1982, PHOSPHOLIPIDS, P129
[6]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[7]   Dietary pectin lowers sphingomyelin concentration in VLDL and raises hepatic sphingomyelinase activity in rats [J].
Bladergroen, BA ;
Beynen, AC ;
Geelen, MJH .
JOURNAL OF NUTRITION, 1999, 129 (03) :628-633
[8]   Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding [J].
Bolin, DJ ;
Jonas, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19152-19158
[9]   The role of lipoprotein lipase and apoprotein E in the recognition of chylomicrons and chylomicron remnants by cultured isolated mouse hepatocytes [J].
Chang, SY ;
Maeda, N ;
Borensztajn, J .
BIOCHEMICAL JOURNAL, 1996, 318 :29-34
[10]  
CHAPPELL DA, 1992, J BIOL CHEM, V267, P25764